FOURTH EXTENSION - GRANTED
granted
on 06 Aug 2024
Last Applicant/ Owned by
Route de la Corniche, 3B
Epalinges
CH
1066
Serial Number
90301418 filed on 05th Nov 2020
Registration Number
N/A
Correspondent Address
Tracy-Gene G. Durkin
Tracy-Gene G. Durkin STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
10th Floor
WASHINGTON, DC 20005
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ADC THERAPEUTICS
Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90301418
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 3309.0030004
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Aug 2024 | SOU EXTENSION 4 FILED |
| 06th Aug 2024 | SOU EXTENSION 4 GRANTED |
| 06th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 09th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th Mar 2024 | CORRECTED NOA E-MAILED |
| 08th Mar 2024 | SOU EXTENSION 3 GRANTED |
| 08th Mar 2024 | DIVISIONAL PROCESSING COMPLETE |
| 27th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 26th Feb 2024 | DIVISIONAL REQUEST RECEIVED |